Prof Monica Morrow speaks to ecancer in an online interview for the virtual BGICC 2021 meeting about managing patients with HER2-positive breast cancer.
She speaks about the benefits of neo-adjuvant therapies for these patients, giving her practical advice for management strategies and discussing recent relevant research.